Skip to main content

news

Indian law firms Cyril Amarchand Mangaldas and AZB & Partners and global law firm Hogan Lovells have advised on non-banking financial company Cholamandalam Investment and Finance’s $480 million qualified institutional placement (QIP).

The QIP transaction involved issuing $240 million in equity and $240 million in CCDs in a single offering, the first of its kind by an Indian company, and also the country’s largest private sector QIP transaction in 2023.

CAM represented Cholamandalam while AZB and Hogan Lovells advised book-running lead managers Kotak Mahindra Capital Company, HSBC Securities and Capital Markets (India)and IIFL Securities.

The CAM team was led by capital markets practice head Yash Ashar and regional co-head of the firm’s southern region market practice, Vijay Parthasarathi.

The AZB team representing the book-running lead managers was led by senior partners Varoon Chandra, Aarthi Sivanandh and Agnik Bhattacharyya.

The Hogan Lovells team was led by Biswajit Chatterjee, Singapore office managing partner and India practice co-chair. U.S.-based partners Henry Kahn and Nancy O’Neil advised on regulatory aspects and U.S. tax matters, respectively.  

Proceeds from the offering will be used for business growth and augment capital adequacy requirements of Cholamandalam, Hogan Lovells said in a statement.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Cleary, A&O Shearman advise on Goodyear's $701 mln Dunlop sale

Cleary Gottlieb has advised tyremaker Goodyear Tire & Rubber Company on the $701 million sale of its Dunlop brand to Japan's Sumitomo Rubber Industries (SRI), which was represented by A&O Shearman.

Mori Hamada, Nagashima Ohno advise on $1.6 bln bid for Fujitsu General

Japanese law firms Mori Hamada & Matsumoto and Nagashima Ohno & Tsunematsu are playing key roles in Paloma Rheem Holdings' 257 billion yen ($1.6 billion) offer to acquire air conditioner manufacturer Fujitsu General.

CAM, Khaitan, Linklaters act on $355 mln Sai Life Sciences IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas has driven the $355 million initial public offering of TPG-backed Indian healthcare R&D firm Sai Life Sciences, with Khaitan & Co and Linklaters advising the bookrunning lead managers. CAM has also acted for selling promoter shareholders Sai Quest Syn.